This month, I profile an under-the-radar European medical services stock which has shown a 10x increase in profits over the past ten years, due to improving margins and mainly organic revenue growth: in a sector with demographic tailwinds. Subscribers can learn why this stock is the latest buy pick and addition to the Real Worth Stocks portfolio.
European medical services stock with strong growth at 13x earnings
